Advanced search
Publication Cover
Infection and Drug Resistance Volume 17, 2024 - Issue
Submit an article Journal homepage
108
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

A Case Report of Urinary Tract Infection and Fungemia Due to Pichia ohmeri Complicated with Pulmonary Thromboembolism

Jiang-Jie Sun1 Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong Province, 518035, People’s Republic of China;2 Department of Pulmonary and Critical Care Medicine, Shenzhen Second People’s Hospital, Shenzhen, Guangdong Province, 518035, People’s Republic of ChinaView further author information
,
Rui Shi1 Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong Province, 518035, People’s Republic of China;2 Department of Pulmonary and Critical Care Medicine, Shenzhen Second People’s Hospital, Shenzhen, Guangdong Province, 518035, People’s Republic of ChinaView further author information
&
He Huang1 Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong Province, 518035, People’s Republic of China;2 Department of Pulmonary and Critical Care Medicine, Shenzhen Second People’s Hospital, Shenzhen, Guangdong Province, 518035, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 11-15 | Received 27 Sep 2023, Accepted 14 Dec 2023, Published online: 02 Jan 2024

References

  • Chakrabarti A, Rudramurthy SM, Kale P, et al. Epidemiological study of a large cluster of fungaemia cases due to Kodamaea ohmeri in an Indian tertiary care centre. Clin Microbiol Infect. 2014;20(2):O83–O89. doi:10.1111/1469-0691.12337
  • Bergman MM, Gagnon D, Doern GV. Pichia ohmeri fungemia. Diagn Microbiol Infect Dis. 1998;30(3):229–231. doi:10.1016/S0732-8893(97)00233-2
  • Ioannou P, Papakitsou I. Kodamaea ohmeri infections in humans: a systematic review. Mycoses. 2020;63(7):636–643. doi:10.1111/myc.13094
  • Shaaban H, Choo HF, Boghossian J, Perez G. Kodamaea ohmeri fungemia in an immunocompetent patient treated with micafungin: case report and review of the literature. Mycopathologia. 2010;170(4):223–228. doi:10.1007/s11046-010-9315-4
  • Shang ST, Lin JC, Ho SJ, et al. The emerging life-threatening opportunistic fungal pathogen Kodamaea ohmeri: optimal treatment and literature review. J Microbiol Immunol Infect. 2010;43(3):200–206. doi:10.1016/S1684-1182(10)60032-1
  • Hemon F, Fouchard F, Tromeur C, et al. Association between hospitalization for acute medical illness and VTE risk: a lower efficacy of thromboprophylaxis in elderly patients? Results from the EDITH case-control study. Eur J Internal Med. 2017;44:39–43. doi:10.1016/j.ejim.2017.05.029
  • Tripodi A, Branchi A, Chantarangkul V, et al. Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay. J Thromb Thrombolysis. 2011;31(2):165–172. doi:10.1007/s11239-010-0506-0
  • Beijers HJBH, Ferreira I, Spronk HMH, et al. Impaired glucose metabolism and type 2 diabetes are associated with hypercoagulability: potential role of central adiposity and low-grade inflammation–the Hoorn Study. Thromb Res. 2012;129(5):557–562. doi:10.1016/j.thromres.2011.07.033
  • Chung WS, Lin CL, Kao CH. Diabetes increases the risk of deep-vein thrombosis and pulmonary embolism. A population-based cohort study. Thromb Haemost. 2015;114(10):812–818. doi:10.1160/TH14-10-0868
  • Ageno W, Becattini C, Brighton T, et al. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation. 2008;117(1):93–102. doi:10.1161/CIRCULATIONAHA.107.709204
  • Konstantinides SV, Meyer G, Becattini C, et al.; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543–603. doi:10.1093/eurheartj/ehz405
  • Lee JS, Shin JH, Kim MN, et al. Kodamaea ohmeri isolates from patients in a University Hospital: identification, antifungal susceptibility, and pulsed-field gel electrophoresis analysis. J Clin Microbiol. 2007;45(3):1005–1010. doi:10.1128/JCM.02264-06
  • García-Martos P, Domínguez I, Marín P, García-Agudo R, Aoufi S, Mira J. Antifungal susceptibility of emerging yeast pathogens. Enferm Infecc Microbiol Clin. 2001;19(6):249–256. In Spanish. doi:10.1016/S0213-005X(01)72630-4
  • Arendrup MC, Boekhout T, Akova M, Meis JF, Cornely OA, Lortholary O; European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; EuropeanConfederation of Medical Mycology. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect. 2014;20(Suppl 3):76–98. doi:10.1111/1469-0691.12360

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.